Oncophenomics is a personalized medicine startup pioneering the latest cutting edge technologies to help improve cancer diagnostics and clinical outcomes

Developer of monoclonal antibody therapeutics to treat cancer and infectious diseases. The company has developed a fully human proprietary mAb technology platform INABLR.